Secondary Hyperparathyroidism Clinical Trial
Official title:
Comparison of Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Without Autotransplantation:A Randomized Clinical Trial
The purpose of this study is to compare short-term and long-term efficacy of total parathyroidectomy with autotransplantation and total parathyroidectomy without autotransplantation for Secondary hyperparathyroidism.
Background:Secondary hyperparathyroidism (SHPT) is a common disorder in patients with
chronic kidney disease. It is caused by permanent stimulation of the orthotopic and
heterotopic parathyroid tissue due to phosphate retention, hypocalcemia, and vitamin D
insufficiency. Despite the initiation of new therapeutic agents, several patients will
require parathyroidectomy.There are three options for the surgical treatment of
SHPT:subtotal PTX (3.5-gland resection,SPTX), total PTX with autotransplantation(TPTX+AT),
and total PTX without autotransplantation(TPTX).SPTX and TPTX+AT both leave a fragment of
activated,proliferated parathyroid tissue.Since the pathophysiological condition of chronic
renal failure and maintenance dialysis continues, the growth stimulus persists and may cause
recurrent sHPT.The SPTX procedure has a lesser likelihood of a non-functioning remnant, but
recurrent disease always requires a neck reoperation that carries a high likelihood of
recurrent laryngeal nerve palsy.Therefore most surgeons believe that TPTX+AT is a better
procedure for patients with SHPT.
Because of the potential complication of permanent hypocalcemia and adynamic bone
disease,TPTX was not introduced into clinical practice.However,recent retrospective studies
demonstrated patients after TPTX did not develop permanent hypoparathyroidism and adynamic
bone disease as initially expected.Postoperative hypocalcemia is temporary.TPTX may provide
an alternative strategy to the currently performed procedures mainly because of the reported
lower recurrence rates.An 8-year follow-up study showed the recurrence rates after TPTX is
7%.Recurrence rates after TPTX+AT is 21.4%,and the site of recurrence is located in
approximately 80% at the graft and in 20% in the neck.However, to the present there is no
randomized controlled trial to Compare the effects of total parathyroidectomy with
autotransplantation and total parathyroidectomy without autotransplantation.The purpose of
this study is to evaluate the short-term and long-term efficacy of total parathyroidectomy
without autotransplantation comparison to total parathyroidectomy with autotransplantation.
Intervention: One hundred patients with SHPT need undergo parathyroidectomy at the Second
Hospital of Anhui medical university were selected and divided into total parathyroidectomy
without autotransplantation group and total parathyroidectomy with autotransplantation
group, each group contains 50 cases.
Results:
1. Clinical data include: intact parathyroid hormone,serum calcium,serum
phosphorus,calcium-phosphorus product,hemoglobin,operation
time,morbidity,mortality,clinical symptoms and signs,recurrence and reoperation,quality
of life scores.
2. Statistical method: groups t-test, analysis of variance were used.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02549417 -
Phase 3 Study of KHK7580
|
Phase 3 | |
Completed |
NCT02549404 -
Phase 3 Study of KHK7580
|
Phase 3 | |
Completed |
NCT02549391 -
Phase 3 Study of KHK7580
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03023748 -
Intravenous Paricalcitol in Chronic Hemodialysis Patients
|
Phase 4 | |
Withdrawn |
NCT01426724 -
Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
|
N/A | |
Completed |
NCT01101113 -
Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level
|
Phase 4 | |
Completed |
NCT01220050 -
Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism
|
Phase 2 | |
Completed |
NCT00537979 -
Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis
|
Phase 4 | |
Completed |
NCT00431496 -
A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)
|
Phase 4 | |
Completed |
NCT00379899 -
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
|
Phase 4 | |
Completed |
NCT00073710 -
Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
|
Phase 4 | |
Completed |
NCT00117052 -
SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism
|
Phase 3 | |
Completed |
NCT03626948 -
SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis
|
Phase 3 | |
Completed |
NCT01382212 -
A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
|
Phase 3 | |
Completed |
NCT01219855 -
Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)
|
Phase 2/Phase 3 | |
Completed |
NCT01224782 -
Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)
|
N/A | |
Completed |
NCT00990704 -
Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism
|
Phase 2 | |
Completed |
NCT00999037 -
FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease
|
N/A | |
Completed |
NCT00742716 -
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
|
Phase 2 | |
Recruiting |
NCT06126016 -
A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
|